Trust Co. of Vermont Sells 1,660 Shares of SPDR S&P Biotech ETF $XBI

Trust Co. of Vermont reduced its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 63.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 973 shares of the exchange traded fund’s stock after selling 1,660 shares during the quarter. Trust Co. of Vermont’s holdings in SPDR S&P Biotech ETF were worth $81,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. JPMorgan Chase & Co. lifted its holdings in shares of SPDR S&P Biotech ETF by 625.1% in the first quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock worth $840,983,000 after buying an additional 12,344,558 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in SPDR S&P Biotech ETF by 33.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock valued at $1,096,866,000 after acquiring an additional 3,353,029 shares during the last quarter. Simplex Trading LLC lifted its stake in SPDR S&P Biotech ETF by 116.1% in the 1st quarter. Simplex Trading LLC now owns 241,039 shares of the exchange traded fund’s stock worth $19,548,000 after purchasing an additional 1,741,445 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at about $85,155,000. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at about $48,660,000.

SPDR S&P Biotech ETF Trading Up 1.2%

Shares of XBI stock opened at $102.59 on Friday. The stock has a market capitalization of $5.59 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 12-month low of $66.66 and a 12-month high of $105.47. The stock’s 50-day moving average price is $91.78 and its 200-day moving average price is $85.05.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.